- Brand name:
- Pharmaceutical Company:
- Condition/Indication: Hepatitis B; Hepatitis C; and Human Immunodeficiency Virus
- Meeting Date: November 2019
- Public Summary Document (PSD) November 2019 PBAC Meeting - (PDF 706KB)
- Public Summary Document (PSD) November 2019 PBAC Meeting - (Word 181KB)
Authorised Nurse Practitioner prescribing for Hepatitis B, Hepatitis C and Human Immunodeficiency Virus medicines under the Highly Specialised Drugs (HSD) Program – November 2019
Authorised Nurse Practitioner prescribing for Hepatitis B, Hepatitis C and Human Immunodeficiency Virus medicines under the Highly Specialised Drugs (HSD) Program
Last updated
9 July 2025